BRME1

gene
On this page

Also known as MGC11271MEIOK21

Summary

BRME1 (break repair meiotic recombinase recruitment factor 1, HGNC:28153) is a protein-coding gene on chromosome 19p13.12, encoding Break repair meiotic recombinase recruitment factor 1 (Q0VDD7). Meiotic recombination factor component of recombination bridges involved in meiotic double-strand break repair.

Predicted to enable damaged DNA binding activity. Predicted to be involved in meiosis I; protein localization to site of double-strand break; and spermatogenesis. Predicted to be located in chromosome. Predicted to be active in site of double-strand break.

Source: NCBI Gene 79173 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 23 total
  • MANE Select transcript: NM_001345843

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28153
Approved symbolBRME1
Namebreak repair meiotic recombinase recruitment factor 1
Location19p13.12
Locus typegene with protein product
StatusApproved
AliasesMGC11271, MEIOK21
Ensembl geneENSG00000132016
Ensembl biotypeprotein_coding
OMIM619276
Entrez79173

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 11 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000346736, ENST00000585755, ENST00000586500, ENST00000586783, ENST00000588115, ENST00000589393, ENST00000591439, ENST00000591586, ENST00000871175, ENST00000871176, ENST00000871177, ENST00000871178, ENST00000871179, ENST00000968796

RefSeq mRNA: 10 — MANE Select: NM_001345843 NM_001345843, NM_001345844, NM_001345846, NM_001345847, NM_001345848, NM_001393645, NM_001393646, NM_001393647, NM_001393648, NM_024323

CCDS: CCDS12299, CCDS92535, CCDS92536

Canonical transcript exons

ENST00000586783 — 9 exons

ExonStartEnd
ENSE000009021121388596113886055
ENSE000010553661388918813890462
ENSE000012391251389278613892890
ENSE000012391311389314213893223
ENSE000012391391389537213895546
ENSE000013694021390486213904913
ENSE000017493831388330813883400
ENSE000027975011388234813882952
ENSE000039229741390571513906117

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 88.23.

FANTOM5 (CAGE): breadth broad, TPM avg 2.1391 / max 45.5164, expressed in 837 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1795751.1426555
1795740.6285306
1795730.200276
1795720.167881

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right testisUBERON:000453488.23gold quality
left testisUBERON:000453387.61gold quality
testisUBERON:000047386.94gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.22gold quality
mucosa of transverse colonUBERON:000499184.80gold quality
sural nerveUBERON:001548884.48gold quality
ventricular zoneUBERON:000305383.34gold quality
ganglionic eminenceUBERON:000402382.73gold quality
cortical plateUBERON:000534381.54gold quality
right hemisphere of cerebellumUBERON:001489080.39gold quality
lower esophagus mucosaUBERON:003583480.11gold quality
cerebellar hemisphereUBERON:000224579.97gold quality
cerebellumUBERON:000203779.92gold quality
cerebellar cortexUBERON:000212979.86gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.55gold quality
body of pancreasUBERON:000115079.13gold quality
esophagus mucosaUBERON:000246978.55gold quality
skin of abdomenUBERON:000141678.39gold quality
duodenumUBERON:000211478.27gold quality
zone of skinUBERON:000001477.92gold quality
skin of legUBERON:000151177.63gold quality
small intestine Peyer’s patchUBERON:000345476.64gold quality
small intestineUBERON:000210876.31gold quality
vaginaUBERON:000099675.88gold quality
transverse colonUBERON:000115775.71gold quality
tibial nerveUBERON:000132375.37gold quality
right uterine tubeUBERON:000130275.16gold quality
right frontal lobeUBERON:000281074.67gold quality
ectocervixUBERON:001224974.37gold quality
C1 segment of cervical spinal cordUBERON:000646974.33gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.86

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

21 targeting BRME1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-366299.9973.825684
HSA-MIR-569699.9872.364487
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-570-3P99.9672.414910
HSA-MIR-185-3P99.9567.011743
HSA-MIR-449699.8868.892236
HSA-MIR-4694-3P99.7969.532640
HSA-MIR-3150A-3P99.7664.441640
HSA-MIR-6763-5P99.7664.681767
HSA-MIR-472999.6972.184233
HSA-MIR-509399.6769.262291
HSA-MIR-317599.6566.302031
HSA-MIR-4786-3P99.3668.351390
HSA-MIR-1211399.3267.541072
HSA-MIR-6799-5P99.1465.722093
HSA-MIR-453998.7867.18888
HSA-MIR-6878-5P98.4967.912142
HSA-MIR-1233-5P98.1966.711201
HSA-MIR-6778-5P98.1966.591239
HSA-MIR-432-5P98.0068.13989
HSA-MIR-444292.3567.0898

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusBrme1ENSMUSG00000008129
rattus_norvegicusBrme1ENSRNOG00000025796

Protein

Protein identifiers

Break repair meiotic recombinase recruitment factor 1Q0VDD7 (reviewed: Q0VDD7)

Alternative names: Pre-T/NK cell-associated protein 3B3

All UniProt accessions (4): Q0VDD7, K7ELK3, K7EMZ7, K7EP60

UniProt curated annotations — full annotation on UniProt →

Function. Meiotic recombination factor component of recombination bridges involved in meiotic double-strand break repair. Modulates the localization of recombinases DMC1:RAD51 to meiotic double-strand break (DSB) sites through the interaction with and stabilization of the BRCA2:HSF2BP complex during meiotic recombination. Indispensable for the DSB repair, homologous synapsis, and crossover formation that are needed for progression past metaphase I, is essential for spermatogenesis and male fertility.

Subunit / interactions. Interacts with HSF2BP (via N-terminus) and BRCA2; the interaction with HSF2BP is direct and allows the formation of a ternary complex. The complex BRME1:HSF2BP:BRCA2 interacts with SPATA22, MEIOB and RAD51.

Subcellular location. Chromosome.

Isoforms (2)

UniProt IDNamesCanonical?
Q0VDD7-11yes
Q0VDD7-22

RefSeq proteins (10): NP_001332772, NP_001332773, NP_001332775, NP_001332776, NP_001332777, NP_001380574, NP_001380575, NP_001380576, NP_001380577, NP_077299 (=MANE)

Domains & families (InterPro)

IDNameType
IPR031441Brme1Family

Pfam: PF15710

UniProt features (18 total): compositionally biased region 6, region of interest 5, sequence variant 2, chain 1, modified residue 1, splice variant 1, sequence conflict 1, helix 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
8A51X-RAY DIFFRACTION1.9

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q0VDD7-F147.230.04

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 370

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 107 (showing top): E2F_Q4, E2F4DP1_01, GOBP_MALE_GAMETE_GENERATION, GGGTGGRR_PAX4_03, E2F1DP1_01, E2F1DP2_01, GOBP_ORGANELLE_FISSION, GOBP_DNA_DAMAGE_RESPONSE, GOBP_FEMALE_GAMETE_GENERATION, E2F1_Q3, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, TAL1BETAE47_01, MODULE_112, MYB_Q5_01

GO Biological Process (4): female meiosis I (GO:0007144), spermatogenesis (GO:0007283), double-strand break repair involved in meiotic recombination (GO:1990918), meiotic cell cycle (GO:0051321)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): chromosome (GO:0005694)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
meiosis I1
female meiotic nuclear division1
female gamete generation1
meiotic cell cycle1
developmental process involved in reproduction1
male gamete generation1
double-strand break repair1
reciprocal meiotic recombination1
meiotic cell cycle process1
cell cycle1
sexual reproduction1
reproductive process1
meiotic nuclear division1
binding1
intracellular membraneless organelle1

Protein interactions and networks

STRING

262 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
BRME1HSF2BPO75031760
BRME1SPATA22Q8NHS9620
BRME1MEIOBQ8N635609
BRME1C19orf67A6NJJ6541
BRME1SYCP3Q8IZU3470
BRME1SYCE2Q6PIF2418
BRME1HORMAD2Q8N7B1409
BRME1HORMAD1Q86X24406
BRME1C19orf53Q9UNZ5400
BRME1SPO11Q9Y5K1394
BRME1RNF212Q495C1390
BRME1C14orf39Q8N1H7379
BRME1ADGRE3Q9BY15374
BRME1FAM222AQ5U5X8371
BRME1SWSAP1Q6NVH7370

IntAct

99 interactions, top by confidence:

ABTypeScore
AIMP2BRME1psi-mi:“MI:0915”(physical association)0.830
BRME1AIMP2psi-mi:“MI:0915”(physical association)0.830
TRIM23BRME1psi-mi:“MI:0915”(physical association)0.670
KRTAP10-9BRME1psi-mi:“MI:0915”(physical association)0.670
BRME1TRIM23psi-mi:“MI:0915”(physical association)0.670
BRME1KRTAP10-9psi-mi:“MI:0915”(physical association)0.670
PSMA6BRME1psi-mi:“MI:0915”(physical association)0.560
RUNX1T1BRME1psi-mi:“MI:0915”(physical association)0.560
BRME1psi-mi:“MI:0915”(physical association)0.560
BRME1KRT38psi-mi:“MI:0915”(physical association)0.560
BRME1KRTAP10-7psi-mi:“MI:0915”(physical association)0.560
BRME1KRT40psi-mi:“MI:0915”(physical association)0.560
BRME1HAUS3psi-mi:“MI:0915”(physical association)0.560
HOMER1BRME1psi-mi:“MI:0915”(physical association)0.560
FAM9BBRME1psi-mi:“MI:0915”(physical association)0.560
BRME1TSC22D3psi-mi:“MI:0915”(physical association)0.560
CTNNAL1BRME1psi-mi:“MI:0915”(physical association)0.560
BRME1PSMA6psi-mi:“MI:0915”(physical association)0.560
BRME1RUNX1T1psi-mi:“MI:0915”(physical association)0.560
BRME1psi-mi:“MI:0915”(physical association)0.560

BioGRID (54): C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), HAUS3 (Two-hybrid), KRT40 (Two-hybrid), FAM9B (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-3 (Two-hybrid), C19orf25 (Two-hybrid)

ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A6NDY2, A6NIJ5, A6NJQ4, A6NKC0, A6NNH2, A6NNJ1, A8MUA0, A8MWA6, A8MX19, A8MXJ8, A8MXZ1, A8MYA2, B1ASB6, D6RGX4, P0C7V4, P0C7W8, P0C7W9, P0C7X0, P0DV73, P0DV74, P0DV75, P0DV76, Q0VDD7, Q2KIS6, Q3UHD3, Q4R736, Q5SZB4, Q5T8A7, Q5VZ46, Q5XIK6, Q658T7, Q6A025, Q6NTE8, Q6PIX9, Q6ZMY3, Q86Y26, Q86YD7

Diamond homologs: Q0VDD7, Q6DIA7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

23 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance6
Likely benign4
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2106 predictions. Top by Δscore:

VariantEffectΔscore
19:13882894:T:TAdonor_gain1.0000
19:13883306:A:ACdonor_gain1.0000
19:13883307:C:CCdonor_gain1.0000
19:13883309:T:TAdonor_gain1.0000
19:13892891:C:CCacceptor_gain1.0000
19:13892899:C:CTacceptor_gain1.0000
19:13892902:A:ACacceptor_gain1.0000
19:13892917:A:Tacceptor_gain1.0000
19:13904857:CGTA:Cdonor_loss1.0000
19:13904858:GTA:Gdonor_loss1.0000
19:13904859:TAC:Tdonor_loss1.0000
19:13904860:A:ACdonor_gain1.0000
19:13904861:C:Adonor_loss1.0000
19:13904861:C:CCdonor_gain1.0000
19:13904913:TC:Tacceptor_loss1.0000
19:13904915:T:Gacceptor_loss1.0000
19:13882877:G:Adonor_gain0.9900
19:13882880:T:TAdonor_gain0.9900
19:13882881:C:Adonor_gain0.9900
19:13882953:C:CCacceptor_gain0.9900
19:13883080:A:Cdonor_gain0.9900
19:13883307:CTT:Cdonor_gain0.9900
19:13883326:A:Cdonor_gain0.9900
19:13883406:C:CTacceptor_gain0.9900
19:13883407:A:Tacceptor_gain0.9900
19:13885956:CCTA:Cdonor_loss0.9900
19:13885957:CTA:Cdonor_loss0.9900
19:13885959:ACC:Adonor_loss0.9900
19:13885960:C:CAdonor_loss0.9900
19:13892779:GCCTT:Gdonor_loss0.9900

AlphaMissense

4311 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:13883320:A:GL615P0.991
19:13882950:C:GR620P0.990
19:13882929:C:GR627P0.986
19:13883311:A:GL618P0.986
19:13883332:A:GL611P0.984
19:13892861:A:CF106L0.984
19:13892861:A:TF106L0.984
19:13892863:A:GF106L0.984
19:13892873:A:CF102L0.981
19:13892873:A:TF102L0.981
19:13892875:A:GF102L0.981
19:13882947:A:GL621P0.977
19:13883320:A:TL615H0.977
19:13882940:C:AM623I0.976
19:13882940:C:GM623I0.976
19:13882940:C:TM623I0.976
19:13883317:G:AS616F0.969
19:13883318:A:GS616P0.968
19:13882923:A:GL629P0.967
19:13883323:T:AE614V0.967
19:13882944:A:TI622N0.965
19:13882910:C:AK633N0.964
19:13882910:C:GK633N0.964
19:13882952:G:CN619K0.964
19:13882952:G:TN619K0.964
19:13882944:A:CI622S0.963
19:13883336:C:GG610R0.963
19:13882933:G:CH626D0.961
19:13883320:A:CL615R0.961
19:13883332:A:TL611H0.960

dbSNP variants (sampled 300 via entrez): RS1000018074 (19:13902990 T>C), RS1000199459 (19:13883530 G>A), RS1000317030 (19:13903302 A>G), RS1000453134 (19:13887149 G>A), RS1000484174 (19:13891949 T>A,C), RS1000566290 (19:13886154 G>A,C), RS1000825751 (19:13897879 A>G), RS1000919214 (19:13904552 C>T), RS1001091248 (19:13898293 T>C), RS1001187639 (19:13902720 T>A,G), RS1001329092 (19:13903785 T>C), RS1001435114 (19:13904279 C>G), RS1001785693 (19:13886583 C>T), RS1001816780 (19:13886326 C>T), RS1001853407 (19:13892184 A>C,G)

Disease associations

OMIM: gene MIM:619276 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST010816_9Gut microbiota beta diversity (weighted UniFrac distance)2.000000e-06
GCST012335_32Hodgkin’s lymphoma9.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007874gut microbiome measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression2
aristolochic acid Iincreases expression1
GSK-J4decreases expression1
FR900359decreases phosphorylation1
bisphenol Aaffects cotreatment, increases methylation1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
aflatoxin B2increases methylation1
(+)-JQ1 compounddecreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Arsenicaffects methylation1
Benzo(a)pyreneaffects methylation1
Caffeinedecreases phosphorylation1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1increases methylation1
Okadaic Acidincreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Hodgkins lymphoma